XERIS BIOPHARMA HOLDINGS, INC. (XERS) Revenue 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$291.8MFY2025 · since FY2020: $20.2M → $291.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $291.8M | +43.7% |
| FY2024 | $203.1M | +23.9% |
| FY2023 | $163.9M | +48.7% |
| FY2022 | $110.2M | +122.3% |
| FY2021 | $49.6M | +146.0% |
| FY2020 | $20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice